Clinical Trials List
2023-10-31 - 2035-12-31
Phase II
Recruiting4
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Yu-De Wang Division of Urology
- Chao-Hsiang Chang Division of Urology
- 陳冠亨 Division of Urology
- 賴俊佑 Division of Urology
- 邱鴻傑 Division of Urology
- Chi-Shun Lien Division of Urology
- Po-Jen Hsiao Division of Urology
- Wei-Ching Lin Division of Radiology
- Yi-Huei Chang Division of Urology
- 蔡禮賢 Division of Urology
- Hsi-Chin Wu Division of Urology
- Han Chang Division of Others -
- Chi-Rei Yang Division of Urology
- Po-Fan Hsieh Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Chieh Lin Division of Urology
- 陳威任 Division of Urology
- 蔡承翰 Division of Urology
- Tzu-Ping Lin Division of Urology
- Tzu-Hsiang Hsu Division of Urology
- William Huang Division of Urology
- Yen-Hwa Chang Division of Urology
- Tzu-Hao Huang Division of Urology
- Tzu-chun Wei Division of Urology
- Jia-An Hong Division of Radiology
- 彭昱璟 Division of Others
- Hsiao-Jen Chung Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王樹吉 Division of Urology
- 洪晟鈞 Division of Urology
- Cheng-Che Chen Division of Urology
- 裘坤元 Division of Urology
- Shian-Shiang Wang 無
- Chia-Yen Lin Division of Urology
- 梅承恩 Division of Urology
- 楊涵中 Division of Urology
- 林雁婷 無
- 張瓈文 Division of Urology
- Cheng-Kuang Yang Division of Urology
- 張家程 Division of Urology
- Chuan-Shu Chen 無
- 賴谷順 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
272 participants
